KBC Group NV Has $736,000 Position in Revvity Inc. $RVTY

KBC Group NV lessened its holdings in Revvity Inc. (NYSE:RVTY) by 78.7% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 8,401 shares of the company’s stock after selling 31,121 shares during the period. KBC Group NV’s holdings in Revvity were worth $736,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently made changes to their positions in the business. Ascentis Independent Advisors bought a new position in shares of Revvity during the 1st quarter worth about $29,000. CYBER HORNET ETFs LLC bought a new stake in Revvity in the second quarter valued at about $32,000. Cromwell Holdings LLC raised its position in Revvity by 141.4% in the fourth quarter. Cromwell Holdings LLC now owns 338 shares of the company’s stock worth $33,000 after purchasing an additional 198 shares in the last quarter. MUFG Securities EMEA plc bought a new position in Revvity during the second quarter worth about $34,000. Finally, SJS Investment Consulting Inc. lifted its stake in Revvity by 5,210.0% during the first quarter. SJS Investment Consulting Inc. now owns 531 shares of the company’s stock worth $47,000 after purchasing an additional 521 shares during the period. Institutional investors and hedge funds own 86.65% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on RVTY. Sanford C. Bernstein began coverage on Revvity in a research note on Friday, June 26th. They issued a “market perform” rating and a $115.00 price objective on the stock. Zacks Research downgraded Revvity from a “hold” rating to a “strong sell” rating in a research report on Monday, July 6th. The Goldman Sachs Group decreased their price target on Revvity from $110.00 to $95.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 14th. Evercore reiterated an “outperform” rating and set a $125.00 price objective on shares of Revvity in a research note on Monday, July 6th. Finally, Weiss Ratings raised Revvity from a “sell (d)” rating to a “sell (d+)” rating in a report on Wednesday, June 24th. Four research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $108.92.

Revvity Stock Performance

NYSE RVTY opened at $110.56 on Friday. The firm has a market cap of $12.33 billion, a price-to-earnings ratio of 52.90, a PEG ratio of 2.17 and a beta of 1.09. The company has a 50 day moving average of $104.90 and a 200-day moving average of $99.61. The company has a current ratio of 1.72, a quick ratio of 1.41 and a debt-to-equity ratio of 0.37. Revvity Inc. has a 1-year low of $81.22 and a 1-year high of $118.30.

Revvity (NYSE:RVTY) last posted its earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.02 by $0.04. The company had revenue of $711.12 million during the quarter, compared to analysts’ expectations of $704.07 million. Revvity had a net margin of 8.26% and a return on equity of 8.00%. Revvity’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.01 earnings per share. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. On average, equities analysts forecast that Revvity Inc. will post 5.25 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Friday, July 17th will be paid a $0.07 dividend. The ex-dividend date of this dividend is Friday, July 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. Revvity’s payout ratio is currently 13.40%.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.